文献速递肾小球疾病

人抗PLA2R1抗体在小型猪中的致病性:一项先导研究

Pathogenicity of Human Anti-PLA 2 R1 Antibodies in Minipigs: A Pilot Study.
PubMed 文献 · J Am Soc Nephrol · 2023-01-05

该先导研究通过被动转移实验,将PLA2R1相关膜性肾病患者血浆或纯化IgG输注给小型猪,观察人抗PLA2R1抗体的致病性。结果显示,小型猪肾小球中可检测到人抗PLA2R1抗体沉积,出现早期膜性肾病组织学特征、局部补体激活及低水平蛋白尿,而健康对照血浆未引起上述改变。结论表明人抗PLA2R1抗体在膜性肾病中具有致病性,但异体相仅出现低水平蛋白尿。

要点

  • 小型猪与人一样,足细胞表达PLA2R1。
  • 被动转移患者抗PLA2R1抗体后,小型猪肾小球出现抗体沉积、补体激活及早期膜性肾病组织学特征。
  • 异体相仅出现低水平蛋白尿,并观察到自体后期疾病相。

核心结论

  • 从人到小型猪的转化研究显示,人抗PLA2R1抗体在膜性肾病中具有致病性,但异体相仅出现低水平蛋白尿。

研究设计与样本

  • 被动转移实验:小型猪接受PLA2R1相关膜性肾病患者或健康对照的血浆或纯化IgG。
  • 采用Western blot、ELISA和考马斯染色监测抗PLA2R1抗体及蛋白尿。
  • 肾组织采用免疫组化、免疫荧光、电镜和蛋白质组学分析。

主要发现

  • 小型猪与人一样,足细胞表达PLA2R1。
  • 人抗PLA2R1抗体在体外和体内均与小型猪PLA2R1结合。
  • 被动转移患者抗PLA2R1抗体后,小型猪出现人早期膜性肾病组织学特征、补体级联成分激活及低水平蛋白尿。
  • 健康对照血浆未引起小型猪肾小球抗体沉积。
  • 观察到自体后期疾病相的发展。

局限性

  • 异体相仅出现低水平蛋白尿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SIGNIFICANCE STATEMENT: Membranous nephropathy (MN) is an autoimmune kidney disease characterized by immune deposits in the glomerular basement membrane. Circulating anti-phospholipase A 2 receptor 1 (PLA 2 R1) antibodies are detectable in 70%-80% of patients with MN, but experimental evidence of pathogenicity has been lacking. This study demonstrates the pathogenicity of human anti-PLA 2 R1 antibodies in minipigs, a model for MN that intrinsically expresses PLA 2 R1 on podocytes. After passive transfer of human anti-PLA 2 R1 antibody-containing plasma from patients with PLA 2 R1-associated MN to minipigs, antibodies were detected in the minipig glomeruli, but not in response to plasma from healthy controls. The minipigs developed histomorphological characteristics of MN, local complement activation in the glomeruli, and low-level proteinuria within 7 days, showing that human anti-PLA 2 R1 antibodies are pathogenic. BACKGROUND: Primary membranous nephropathy (MN) is an autoimmune kidney disease in which immune complexes are deposited beneath the epithelium in the glomeruli. The condition introduces a high risk for end-stage kidney disease. Seventy percent to 80% of patients with MN have circulating antibodies against phospholipase A 2 receptor 1 (PLA 2 R1), and levels correlate with treatment response and prognosis. However, experimental evidence that human anti-PLA 2 R1 antibodies induce MN has been elusive. METHODS: In passive transfer experiments, minipigs received plasma or purified IgG from patients with PLA 2 R1-associated MN or from healthy controls. Anti-PLA 2 R1 antibodies and proteinuria were monitored using Western blot, ELISA, and Coomassie staining. Kidney tissues were analyzed using immunohistochemistry, immunofluorescence, electron microscopy, and proteomic analyses. RESULTS: Minipigs, like humans, express PLA 2 R1 on podocytes. Human anti-PLA 2 R1 antibodies bound to minipig PLA 2 R1 in vitro and in vivo . Passive transfer of human anti-PLA 2 R1 antibodies from patients with PLA 2 R1-associated MN to minipigs led to histological characteristics of human early-stage MN, activation of components of the complement cascade, and low levels of proteinuria. We observed development of an autologous, later phase of disease. CONCLUSIONS: A translational approach from humans to minipigs showed that human anti-PLA 2 R1 antibodies are pathogenic in MN, although in the heterologous phase of disease only low-level proteinuria developed.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Reinhard L, Wiech T, Reitmeier A, et al. Pathogenicity of Human Anti-PLA 2 R1 Antibodies in Minipigs: A Pilot Study. J Am Soc Nephrol. 2023. PMID: 36735391. doi:10.1681/ASN.0000000000000068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。